DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Vanguard Complete Knee Versus Vanguard High Flex Rotating Platform (RP) Knee Study

Information source: Biomet, Inc.
Information obtained from ClinicalTrials.gov on December 08, 2011
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Osteoarthritis; Rheumatoid Arthritis; Traumatic Arthritis

Intervention: Vanguard Complete Knee System w/ std tray (Device); Vanguard High Flex RP (Device)

Phase: N/A

Status: Recruiting

Sponsored by: Biomet, Inc.

Official(s) and/or principal investigator(s):
Myung-Chul Lee, M.D., Ph.D., Principal Investigator, Affiliation: Seoul National University Hospital
Chul-Won Ha, M.D., Ph.D., Principal Investigator, Affiliation: Samsung Medical Center
Seong-Il Bin, M.D., Ph.D., Principal Investigator, Affiliation: Asan Medical Center
Yong In, M.D., Ph.D., Principal Investigator, Affiliation: Catholic University Uijungbu St. Mary's Hospital

Overall contact:
Dawn Lim, Phone: +82 2 567 8550, Email: dawn.lim@biomet.com

Summary

The purpose of this study is to compare Vanguard High Flex Rotating Platform to Vanguard Complete Knee System in Asian population in terms of early range of motion (ROM), clinical outcomes, and kinetic and kinematic characteristics in relation to healthy knees.

Clinical Details

Official title: A Prospective Controlled Multi-center Study on Vanguard Complete Knee and Vanguard High Flex RP Knee

Study design: Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: American Knee Society Knee Score, including ROM

Secondary outcome:

Kinematic Fluoroscopic Analysis

Gait Lab Analysis

EQ5D

Radiographic Assessment

Detailed description: The primary objectives of this clinical study include:

- Evaluate size fit and long term performance of Vanguard Complete Knee ("Fixed") System

in Asian and Latino population in comparison to competitor's similar product.

- Evaluate efficacy of Vanguard Complete Knee with Microplasty Tibial Tray.

- Compare Vanguard High Flex Rotating Platform ("High Flex") Knee System to Vanguard

Complete Knee System in Asian population in terms of:

- Early ROM

- Clinical outcomes

- Kinetic and Kinematic characteristics in relation to Healthy Knees. o

- Compare current design to new design of Vanguard High Flex Rotating Platform Knee

System in terms of :

- Early ROM

- Clinical outcomes

- Kinetic and Kinematic characteristics

Eligibility

Minimum age: 21 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Painful and disabled knee joint resulting form osteoarthritis, rheumatoid arthritis,

traumatic arthritis where one or more compartments are involved.

- Correction of varus, valgus, or posttraumatic deformity.

- Correction or revision of unsuccessful osteotomy, or arthrodesis.

- Need to obtain pain relief and improve function.

- Ability and willingness of the patient to follow instructions, including control of

weight and activity level.

- Good nutritional state of the patient.

- Patient must have reached full skeletal maturity.

Exclusion Criteria:

- Infection, sepsis, osteomyelitis, and failure of previous joint replacement.

- Uncooperative patient or patients with neurologic disorders who are incapable of

following directions.

- Osteoporosis

- Metabolic disorders which may impair bone formation

- Osteomalacia

- Distant foci of infections which may spread to the implant site

- Rapid joint destruction, marked bone loss or bone resorption apparent on

roentgenogram

- Vascular insufficiency, muscular atrophy, neuromuscular disease

- Incomplete or deficient soft tissue surrounding the knee

Locations and Contacts

Dawn Lim, Phone: +82 2 567 8550, Email: dawn.lim@biomet.com

Samsung Medical Center, Seoul, Korea, Republic of; Recruiting
Additional Information

Starting date: October 2009
Last updated: June 7, 2011

Page last updated: December 08, 2011

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012